These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37902120)

  • 1. Overview of current applications and trends in artificial intelligence for cystoscopy and transurethral resection of bladder tumours.
    Ikeda A; Nosato H
    Curr Opin Urol; 2024 Jan; 34(1):27-31. PubMed ID: 37902120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of artificial intelligence for the diagnosis of bladder cancer: a review and perspectives.
    Chan EO; Pradere B; Teoh JY;
    Curr Opin Urol; 2021 Jul; 31(4):397-403. PubMed ID: 33978604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Support System of Cystoscopic Diagnosis for Bladder Cancer Based on Artificial Intelligence.
    Ikeda A; Nosato H; Kochi Y; Kojima T; Kawai K; Sakanashi H; Murakawa M; Nishiyama H
    J Endourol; 2020 Mar; 34(3):352-358. PubMed ID: 31808367
    [No Abstract]   [Full Text] [Related]  

  • 5. Artificial Intelligence for Segmentation of Bladder Tumor Cystoscopic Images Performed by U-Net with Dilated Convolution.
    Mutaguchi J; Morooka K; Kobayashi S; Umehara A; Miyauchi S; Kinoshita F; Inokuchi J; Oda Y; Kurazume R; Eto M
    J Endourol; 2022 Jun; 36(6):827-834. PubMed ID: 35018828
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New optical imaging technologies for bladder cancer: considerations and perspectives.
    Liu JJ; Droller MJ; Liao JC
    J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
    Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
    Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U-Net-Based Assistive Identification of Bladder Cancer: A Promising Approach for Improved Diagnosis.
    Guo Y; Li C; Zhang S; Zhu G; Sun L; Jin T; Wang Z; Li S; Zhou F
    Urol Int; 2024; 108(2):100-107. PubMed ID: 38081150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors.
    Ali N; Bolenz C; Todenhöfer T; Stenzel A; Deetmar P; Kriegmair M; Knoll T; Porubsky S; Hartmann A; Popp J; Kriegmair MC; Bocklitz T
    Sci Rep; 2021 Jun; 11(1):11629. PubMed ID: 34079004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented Bladder Tumor Detection Using Deep Learning.
    Shkolyar E; Jia X; Chang TC; Trivedi D; Mach KE; Meng MQ; Xing L; Liao JC
    Eur Urol; 2019 Dec; 76(6):714-718. PubMed ID: 31537407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
    Richards KA; Smith ND; Steinberg GD
    J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
    Herr HW
    Eur Urol; 2015 Apr; 67(4):605-8. PubMed ID: 25041849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy.
    Tschirdewahn S; Harke NN; Hirner L; Stagge E; Hadaschik B; Eisenhardt A
    World J Urol; 2020 Jun; 38(6):1509-1515. PubMed ID: 31471739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
    Soria F; Gurioli A; Peraldo F; Oderda M; Giona S; Ambrosini E; Frea B; Gontero P
    Urologia; 2013 Jun; 80 Spec No 1():1-8. PubMed ID: 23813287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures.
    O'Sullivan S; Janssen M; Holzinger A; Nevejans N; Eminaga O; Meyer CP; Miernik A
    World J Urol; 2022 May; 40(5):1125-1134. PubMed ID: 35084542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer.
    Sung HH; Scherr DS; Slaton J; Liu H; Feeny KL; Lingley-Papadopoulos C; Gearheart J; Zara JM; Lerner SP
    Urol Oncol; 2021 Jul; 39(7):434.e23-434.e29. PubMed ID: 33934964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.